Aarti Pharmalabs Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aarti Pharmalabs Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 52% to $18,155,052,000. The net income raised on $2,169,020,000 and profit margin reached 12%. Total operating expenses were $7,006,674,000.

Profit Margin

Aarti Pharmalabs Limited (NSE:AARTIPHARM.NS): Profit margin
2021 0 -45.96K
2022 11.93B -771.37K -0.01%
2024 18.15B 2.16B 11.95%

AARTIPHARM.NS Income Statement (2020 – 2023)

2023 2021 2020
Revenue
Revenue
18.15B11.93B0
Cost of revenue
14.24B10.01B0
Gross profit
3.90B1.92B0
Operating exp.
Research and development
83.70M58.15M0
Selling and marketing
679.71M261.36M0
Total operating expenses
7.00B785.66K45.96K
Operating income
3.12B-769.76K-45.96K
Other income (expenses), net
-123.19M-1.61K0
Income before tax
3.00B-771.37K-45.96K
Income tax expense
835.89M331.29M-46K
Net income
2.16B-771.37K-45.96K
Earnings per share
Basic EPS
23.93-0.00-0.18
Diluted EPS
23.93-0.00-0.18
Data sourceData sourceData source